tiprankstipranks
OncoCyte Corp (OCX)
NASDAQ:OCX
US Market

OncoCyte (OCX) Income Statement

Compare
422 Followers

OncoCyte Income Statement

Last quarter (Q4 2024), OncoCyte's total revenue was $1.49M, an increase of 373.25% from the same quarter last year. In Q4, OncoCyte's net income was $-33.51M. See OncoCyte’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 1.88M$ 1.50M$ 958.00K$ 7.73M$ 1.22M
Gross Profit
$ 740.00K$ 413.00K$ -18.00K$ 188.00K$ -639.00K
Operating Expenses
$ 60.64M$ 25.64M$ 30.31M$ 47.13M$ 33.08M
Depreciation and Amortization
$ 1.56M$ 1.68M$ 5.22M$ 4.21M$ 394.00K
EBITDA
$ -59.02M$ -23.12M$ -13.31M$ -48.46M$ -30.54M
Operating Income
$ -61.04M$ -25.14M$ -18.00M$ -46.95M$ -29.71M
Other Income/Expenses
$ 378.00K$ 281.00K$ -615.00K$ 854.00K$ -1.48M
Pretax Income
$ -60.66M$ -24.86M$ -18.61M$ -73.36M$ -31.19M
Net Income
$ -60.66M$ -27.78M$ -73.44M$ -64.10M$ -29.93M
Per Share Metrics
Basic EPS
$ -4.64$ -3.75$ -13.26$ -14.42$ -9.14
Diluted EPS
$ -4.64$ -3.75$ -13.26$ -14.42$ -9.14
Weighted Average Shares Outstanding
13.07M 7.65M 5.54M 4.45M 3.27M
Weighted Average Shares Outstanding (Diluted)
13.07M 7.65M 5.54M 4.45M 3.27M
Currency in USD

OncoCyte Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis